About New Iridium
New Iridium is a company based in Boulder (United States) founded in 2016 by Garrett Miyake, Chern-Hooi Lim, and Brent Cutcliffe. New Iridium has raised $2.65 million across 6 funding rounds from investors including HHS, CIRI Ventures and National Science Foundation. New Iridium operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Liverpool ChiroChem, SpiroChem and IRBM, among others.
- Headquarter Boulder, United States
- Founders Garrett Miyake, Chern-Hooi Lim, Brent Cutcliffe
- SectorsHealthcare
- Website newiridium.com
- Social LinkedIn X
- Total Equity Funding$2.65M (USD)
in 6 rounds
- Latest Funding Round$2.65M (USD), Seed
Jun 2025
- InvestorsHHS
& 6 more
Funding Insights of New Iridium
New Iridium has successfully raised a total of $2.65M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $2.65 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.65M
- Total Rounds 6
- Last Round Seed — $2.65M
- First Round $1.72M
(Feb 2019)
- Investors Count 7
All 6 funding rounds of New Iridium with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2025 | $2.65M | Seed | – | Radicle, CIRI Ventures | |
| Jul 2024 | $200,000 | Grant | – | – | |
| Jun 2023 | $1M | Grant | – | – | |
| May 2020 | $256,000 | Grant | – | – | |
| Jan 2020 | $224,999 | Grant | – | – | |
| Feb 2019 | $1.72M | Grant | – | – |
7 investors in total: 7 institutional.
Investors in New Iridium
New Iridium has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, CIRI Ventures and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by the US Government | – | seedfund.nsf.gov | Alexandria, United States | |
- | – | radicle.vc | - | |
Investment firm fueling climate innovation at pre-seed and seed stages | – | ciri.ventures | - | |
Climate tech startups are supported through funding and resources. | – | evergreeninno.org | Chicago, United States | |
Climate tech investment opportunities are facilitated by Climate Insiders. | – | climateinsiders.com | - | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for New Iridium
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of New Iridium
3 people are tracked at New Iridium (3 in leadership).
| Name | Role | Group |
|---|---|---|
Garrett Miyake | Co-Founder & CTO | Leadership |
Chern-Hooi Lim | Founder & CEO | Leadership |
Brent Cutcliffe | Co-Founder & COO | Leadership |
Complete people profiles for New Iridium
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of New Iridium
3 dated milestones of New Iridium across 9 years, from founding to its latest funding, stage changes and deals.
- Founded New Iridium is founded.
- Funding First funding round of $1.7M.
- Funding Latest funding round, Seed, of $2.6M.
Competitors of New Iridium
New Iridium operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Liverpool ChiroChem, SpiroChem and IRBM, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sailife.com | 1999 | Hyderabad, India | $112.18M | 2,948 | Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. | |
| aciesbio.com | 2006 | Ljubljana, Slovenia | – | – | Provider of drug discovery and development services to pharmaceutical, biotech, and food industries | |
| liverpoolchirochem.com | 2014 | Liverpool, United Kingdom | $11.07M | 14 | Small organic molecules are supplied for biotech and pharmaceutical R&D. | |
| spirochem.com | 2011 | Zurich, Switzerland | – | – | Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry | |
| irbm.com | 2010 | Pomezia, Italy | – | – | Integrated drug discovery and preclinical development services are provided. | |
| personalchemistry.com | 1998 | Uppsala, Sweden | $50.46M | – | Coherent Synthesis is developed for medicinal and combinatorial chemistry applications. | |
| nfil.in | 1967 | Mumbai, India | – | 1,476 | Fluorinated compounds are synthesized and manufactured customly for various industries. | |
| automeratx.com | 2022 | Singapore | $16M | – | Autophagy-driven degradation is pioneered through computational chemistry and AI. |
Detailed competitors of New Iridium
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of New Iridium
The website of New Iridium (newiridium.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▼ 30.8% vs previous month
Latest news on New Iridium
Complete news archive for New Iridium
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to New Iridium
10 companies that operate in the same segment as New Iridium (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about New Iridium
New Iridium was founded in 2016 and raised its 1st funding round 3 years after it was founded.
New Iridium is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Chern-Hooi Lim is the current CEO of New Iridium. They have also founded this company.
New Iridium is a funded company, having raised a total of $2.65M across 6 funding rounds to date. The company's 1st funding round was a Grant of $1.72M, raised on Feb 2019.
New Iridium was established in 2016 and is based in Boulder, United States. Operations center on chemical manufacturing, with a focus on producing phenoxazine and dihydrophenazine compounds. The company is led by co-founders Chern-Hooi Lim as CEO, Garrett Miyake as CTO, and Brent Cutcliffe as COO. Activities are conducted within the specialty chemicals sector, serving industrial needs through targeted synthesis processes.
New Iridium's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
New Iridium has 7 investors. Key investors include HHS, CIRI Ventures, National Science Foundation, America’s Seed Fund, and Radicle.